Another study identified ERp57/PDIA3 as being indirectly involved, with a mutant calreticulin gene (CALR), in altered Ca2+ mobilization in patients with myeloproliferative neoplasms. This evidence concerns the gene CALR and myeloproliferative neoplasm.